Issue

Vol. 66 No. 3: Issue 3

The undersigned hereby assign all rights, included but not limited to copyright, for this manuscript to CMB Association upon its submission for consideration to publication on Cellular and Molecular Biology. The rights assigned include, but are not limited to, the sole and exclusive rights to license, sell, subsequently assign, derive, distribute, display and reproduce this manuscript, in whole or in part, in any format, electronic or otherwise, including those in existence at the time this agreement was signed. The authors hereby warrant that they have not granted or assigned, and shall not grant or assign, the aforementioned rights to any other person, firm, organization, or other entity. All rights are automatically restored to authors if this manuscript is not accepted for publication.

Influenced CD cells and ICAM-1 by pulmonary surfactant combined with high-frequency oscillatory ventilation and its effects on immune function in children with neonatal respiratory distress syndrome

https://doi.org/10.14715/cmb/2020.66.3.5
Lijie Su
Department of Obstetrics, The Fourth Hospital of Harbin Medical University, Harbin 150000, China
Qiuyu Sun
Department of Gynecology and Obstetrics, The Fourth Hospital of Harbin Medical University, Harbin 150000, China
Wenfang Cai
Department of Minimally Invasive Neurosurgery, The Fourth Hospital of Harbin Medical University, Harbin 150000, China
Ying Qi
Department of Orthopedics, The Fourth Hospital of Harbin Medical University, Harbin 150000, China

Corresponding Author(s) : Qiuyu Sun

qiuyusun@mail.ru

Cellular and Molecular Biology, Vol. 66 No. 3: Issue 3

Abstract

This study aimed to explore the clinical efficacy of pulmonary surfactant combined with high-frequency oscillatory ventilation (HFOV) on neonatal respiratory distress syndrome (NRDS) and its influence on immune function in children. Children admitted to our hospital from March 2017 to March 2019 who received HFOV combined with pulmonary surfactant therapy as a research group. Sixty-two children received conventional nasal continuous positive pressure combined with pulmonary surfactant therapy as a control group. Clinical efficacy, blood gas and immune function of patients were compared between the two groups. The clinical efficacy of the research group was better than that of the control group (P< 0.050). PaO2 and PaO2/FiO2 were both higher after treatment (P< 0.050). CD3+ and NK cells in the research group were higher than those in the control group, while CD8+ cells and ICAM-1 were lower than those in the control group (P< 0.050). CD3+, CD4+ and NK cells decreased in both groups after treatment, while CD8+ cells and ICAM-1 increased (P< 0.050). HFOV combined with pulmonary surfactant has significant clinical efficacy and high safety on NRDS, and has a certain protective effect on children's immune function. Hence, it is worthy of being the first choice for the clinical treatment of NRDS in the future.

Keywords

HFOV NRDS Nasal continuous positive pressure. Pulmonary surfactant T-lymphocyte subsets.
Su, L., Sun, Q., Cai, W., & Qi, Y. (2020). Influenced CD cells and ICAM-1 by pulmonary surfactant combined with high-frequency oscillatory ventilation and its effects on immune function in children with neonatal respiratory distress syndrome. Cellular and Molecular Biology, 66(3), 32–38. https://doi.org/10.14715/cmb/2020.66.3.5
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX
References
  1. Sweet DG, Carnielli V, Greisen G, Hallman M, Ozek E, Plavka R, Saugstad OD, Simeoni U, Speer CP, Vento M: European consensus guidelines on the management of respiratory distress syndrome-2016 update. Neonatology 111: 107-125, 2017.
  2. Aldana-Aguirre JC, Pinto M, Featherstone RM, Kumar M: Less invasive surfactant administration versus intubation for surfactant delivery in preterm infants with respiratory distress syndrome: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed 102: F17-F23, 2017.
  3. Hiles M, Culpan AM, Watts C, Munyombwe T, Wolstenhulme S: Neonatal respiratory distress syndrome: chest X-ray or lung ultrasound? A systematic review. Ultrasound 25: 80-91, 2017.
  4. Schouten LR, Veltkamp F, Bos AP, van Woensel JB, Serpa Neto A, Schultz MJ, Wösten-van Asperen RM: Incidence and mortality of acute respiratory distress syndrome in children: a systematic review and meta-analysis. Crit Care Med 44: 819-829, 2016.
  5. Tochie JN, Choukem SP, Langmia RN, Barla E, Koki-Ndombo P: Neonatal respiratory distress in a reference neonatal unit in Cameroon: an analysis of prevalence, predictors, etiologies and outcomes. Pan Afr Med J 24: 152, 2016.
  6. Kallio M, Koskela U, Peltoniemi O, Kontiokari T, Pokka T, Suo-Palosaari M, Saarela T: Neurally adjusted ventilatory assist (NAVA) in preterm newborn infants with respiratory distress syndrome”a randomized controlled trial. Eur J Pediatr 175: 1175-1183, 2016.
  7. Wong JJ, Jit M, Sultana R, Mok YH, Yeo JG, Koh JWJC, Loh TF, Lee JH: Mortality in pediatric acute respiratory distress syndrome: a systematic review and meta-analysis. J Intensive Care Med 34: 563-571, 2019.
  8. Sardesai S, Biniwale M, Wertheimer F, Garingo A, Ramanathan R: Evolution of surfactant therapy for respiratory distress syndrome: past, present, and future. Pediatr Res 81: 240-248, 2017.
  9. Klotz D, Schaefer C, Stavropoulou D, Fuchs H, Schumann S: Leakage in nasal high"frequency oscillatory ventilation improves carbon dioxide clearance”A bench study. Pediatr Pulmonol 52: 367-372, 2017.
  10. Sklar MC, Fan E, Goligher EC: High-frequency oscillatory ventilation in adults with ARDS: past, present, and future. Chest 152: 1306-1317, 2017.
  11. Viteri OA, Blackwell SC, Chauhan SP, Refuerzo JS, Pedroza C, Salazar XC, Sibai BM: Antenatal corticosteroids for the prevention of respiratory distress syndrome in premature twins. Obstet Gynecol 128: 583-591, 2016.
  12. Jasani B, Kabra N, Nanavati R: Surfactant replacement therapy beyond respiratory distress syndrome in neonates. Indian Pediatr 53: 229-234, 2016.
  13. Rezoagli E, Fumagalli R, Bellani G: Definition and epidemiology of acute respiratory distress syndrome. Ann Transl Med 5: 282, 2017.
  14. Gupta S, Donn SM: Continuous positive airway pressure: physiology and comparison of devices. In: Seminars in Fetal and Neonatal Medicine. WB Saunders 21: 204-211, 2016.
  15. González-Pacheco N, Sánchez-Luna M, Ramos-Navarro C, de la Blanca AR: Using very high frequencies with very low lung volumes during high-frequency oscillatory ventilation to protect the immature lung. A pilot study. J Perinatol 36: 306-310, 2016.
  16. Rowan CM, Loomis A, McArthur J, Smith LS, Gertz SJ, Fitzgerald JC, Nitu ME, Moser EA, Hsing DD, Duncan CN: High-frequency oscillatory ventilation use and severe pediatric ARDS in the pediatric hematopoietic cell transplant recipient. Respir Care 63: 404-411, 2018.
  17. Ethawi YH, Mehrem AA, Minski J, Ruth CA, Davis PG: High frequency jet ventilation versus high frequency oscillatory ventilation for pulmonary dysfunction in preterm infants. Cochrane Database Syst Rev 5: CD010548, 2016 .
  18. Ke H, Li ZK, Yu XP, Guo JZ: Efficacy of different preparations of budesonide combined with pulmonary surfactant in the treatment of neonatal respiratory distress syndrome: a comparative analysis. Zhongguo dang dai er ke za zhi= Chinese journal of contemporary pediatrics 18: 400-404, 2016.
  19. Liu J, Liu G, Wu H, Li Z: Efficacy study of pulmonary surfactant combined with assisted ventilation for acute respiratory distress syndrome management of term neonates. Exp Ther Med 14: 2608-2612, 2017.
  20. Autilio C, Echaide M, Benachi A, Marfaing-Koka A, Capoluongo ED, Pérez-Gil J, De Luca D: A noninvasive surfactant adsorption test predicting the need for surfactant therapy in preterm infants treated with continuous positive airway pressure. J Pediatr 182: 66-73. e1, 2017.
  21. Samransamruajkit R, Rassameehirun C, Pongsanon K, Huntrakul S, Deerojanawong J, Sritippayawan S, Prapphal N: A comparison of clinical efficacy between high frequency oscillatory ventilation and conventional ventilation with lung volume recruitment in pediatric acute respiratory distress syndrome: A randomized controlled trial. Indian J Crit Care Med 20: 72-77, 2016.
  22. Laviola M, Rafl J, Rozanek M, Kudrna P, Roubik K: Models of PaO2 response to the continuous distending pressure maneuver during high frequency oscillatory ventilation in healthy and ARDS lung model pigs. Exp Lung Res 42: 87-94, 2016.
  23. Villar J, Ambrós A, Soler JA, Martí­nez D, Ferrando C, Solano R, Mosteiro F, Blanco J, Martí­n-Rodrí­guez C, Fernández MM: Age, PaO2/FIO2, and plateau pressure score: a proposal for a simple outcome score in patients with the acute respiratory distress syndrome. Crit Care Med 44: 1361-1369, 2016.
  24. Hsia CCW, Ravikumar P, Ye J: Acute lung injury complicating acute kidney injury: A model of endogenous αKlotho deficiency and distant organ dysfunction. Bone 100: 100-109, 2017.
  25. Doi K, Rabb H: Impact of acute kidney injury on distant organ function: recent findings and potential therapeutic targets. Kidney Int 89: 555-564, 2016.
  26. Guervilly C, Forel JM, Hraiech S, Roch A, Talmor D, Papazian L: Effect of high-frequency oscillatory ventilation on esophageal and transpulmonary pressures in moderate-to-severe acute respiratory distress syndrome. Ann Intensive Care 6: 84, 2016.
  27. Greuter T, Biedermann L, Rogler G, Sauter B, Seibold F: Alicaforsen, an antisense inhibitor of ICAM-1, as treatment for chronic refractory pouchitis after proctocolectomy: A case series. United European Gastroenterol J 4: 97-104, 2016.
  28. Dwivedi VP, Bhattacharya D, Singh M, Bhaskar A, Kumar S, Fatima S, Sobia P, Kaer LV, Das G: Allicin enhances antimicrobial activity of macrophages during Mycobacterium tuberculosis infection. J Ethnopharmacol 243: 111634, 2019.
  29. Yehya N, Thomas NJ, Meyer NJ, Christie JD, Berg RA, Margulies SS: Circulating markers of endothelial and alveolar epithelial dysfunction are associated with mortality in pediatric acute respiratory distress syndrome. Intensive Care Med 42: 1137-1145, 2016.
Read More
Author biographies is not available.
Crossref
Scopus
Google Scholar
Europe PMC
Download this PDF file
PDF
Statistic
Read Counter : 794 Download : 462